Weis Markets posts Q2 2026 revenue of $1.28B
Weis Markets, Inc. reported second quarter 2026 results for the 13 weeks ended June 27, 2026.
Rhea-AI Filing Summary
Weis Markets, Inc. reported second quarter 2026 results for the 13 weeks ended June 27, 2026. Total revenue was $1.28 billion, up 4.6% from 2025, with comparable store sales up 2.3% and 4.1% on a two-year stacked basis. Pharmacy revenue growth was reduced by approximately $10.71 million due to Medicare maximum fair price provisions under the Inflation Reduction Act. Net income for the quarter was $22.86 million versus $25.28 million, and earnings per share were $0.92 versus $0.96.
For the 26-week period, revenue rose 4.6% to $2.53 billion, and net income increased 13.1% to $50.71 million, with EPS of $2.05 compared with $1.69. The board declared a quarterly cash dividend of $0.34 per share, payable August 10, 2026 to shareholders of record on July 27, 2026.
Positive
- Year-to-date profitability strengthened: net income rose 13.1% to $50.71 million and EPS increased to $2.05 from $1.69 for the 26 weeks ended June 27, 2026.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
comparable store sales financial
two-year stacked comparable store sales financial
Inflation Reduction Act Medicare maximum fair price provisions regulatory
forward-looking statements regulatory
non-GAAP financial
Earnings Snapshot
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were Weis Markets (WMK) second quarter 2026 revenue and growth?
How did Weis Markets (WMK) second quarter 2026 earnings compare to 2025?
What are Weis Markets (WMK) year-to-date 2026 financial results?
How did comparable store sales trend for Weis Markets (WMK) in Q2 2026?
What dividend did Weis Markets (WMK) declare in July 2026?
How did the Inflation Reduction Act affect Weis Markets (WMK) pharmacy revenue in 2026?
AI-generated analysis. How Rhea-AI works. Not financial advice.
